Actinium Pharmaceuticals, Inc. SEC filings ATNM
Actinium Pharmaceuticals, Inc. has 511 filings in SEC EDGAR's recent list, going back to Feb 5, 2007. Its latest annual report, Form ARS, was filed on Oct 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 16, 2026 | Oct 14, 2026 |
| 3 | Initial insider ownership | Oct 16, 2026 | Oct 14, 2026 |
| ARS | Annual report to shareholders | Oct 15, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Oct 15, 2026 | Nov 25, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 15, 2026 | Oct 14, 2026 |
| S-8 | Employee stock plan registration | Oct 9, 2026 | — |
| 3 | Initial insider ownership | Sep 10, 2026 | Sep 3, 2026 |
| 3 | Initial insider ownership | Sep 10, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 14, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
May 29, 2026 | May 27, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Mar 26, 2026 | Nov 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 26, 2025 | Nov 26, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Nov 5, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Nov 5, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Aug 20, 2025 | Aug 18, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Auditor change
|
May 9, 2025 | May 8, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 27, 2024 | Nov 27, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| ARS | Annual report to shareholders | Nov 6, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 3 | Initial insider ownership | Nov 5, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 5, 2024 | Nov 1, 2024 |
| DEF 14A | Proxy statement | Nov 5, 2024 | Nov 27, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 4, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 5, 2024 | Aug 5, 2024 |
| 10-Q | Quarterly report | Apr 26, 2024 | Mar 31, 2024 |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| EFFECT | Filing | Feb 5, 2024 | — |
| S-3/A | Pre-effective amendment no. 1 to form s-3 | Feb 2, 2024 | — |
| CORRESP | Letter to the SEC | Feb 2, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 29, 2024 | — |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 1, 2023 | Nov 30, 2023 |
| ARS | Annual report to shareholders | Nov 9, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Nov 9, 2023 | Nov 30, 2023 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Aug 17, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| S-3 | Shelf registration | Aug 11, 2023 | — |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 21, 2023 | Feb 18, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 30, 2022 | Dec 30, 2022 |
| DEFA14A | Additional proxy material | Dec 9, 2022 | — |
| 8-K |
Current report
Other events
|
Dec 9, 2022 | Dec 8, 2022 |
| DEF 14A | Proxy statement | Nov 21, 2022 | Dec 8, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2022 | Oct 31, 2022 |
| S-8 | Employee stock plan registration | Aug 19, 2022 | — |
| 4 | Insider transaction | Aug 19, 2022 | Aug 17, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 4 | Insider transaction | Jul 1, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 1, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 1, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 1, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 1, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 1, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 29, 2022 | Jun 28, 2022 |
| 424B3 | Prospectus | Jun 28, 2022 | — |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Material agreement
|
Apr 13, 2022 | Apr 7, 2022 |
| 10-K | Annual report | Mar 25, 2022 | Dec 31, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2022 | — |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 9, 2021 | Nov 9, 2021 |
| DEFA14A | Additional proxy material | Nov 5, 2021 | — |
| DEF 14A | Proxy statement | Oct 18, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 23, 2021 | Sep 22, 2021 |
| 4 | Insider transaction | Sep 3, 2021 | Sep 1, 2021 |
| 4 | Insider transaction | Sep 3, 2021 | Sep 1, 2021 |
| 4 | Insider transaction | Sep 3, 2021 | Sep 1, 2021 |
| 4 | Insider transaction | Sep 3, 2021 | Sep 1, 2021 |
| 4 | Insider transaction | Sep 3, 2021 | Sep 1, 2021 |
| 4 | Insider transaction | Sep 3, 2021 | Sep 1, 2021 |
| 4 | Insider transaction | Sep 3, 2021 | Sep 1, 2021 |
| 10-Q | Quarterly report | Jul 30, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 5, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 20, 2020 | Nov 18, 2020 |
| DEFA14A | Additional proxy material | Oct 28, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2020 | Oct 28, 2020 |
| 10-Q | Quarterly report | Oct 23, 2020 | Sep 30, 2020 |
| DEFA14A | Additional proxy material | Oct 7, 2020 | — |
| DEF 14A | Proxy statement | Oct 7, 2020 | Nov 18, 2020 |
| EFFECT | Filing | Aug 14, 2020 | — |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Aug 14, 2020 | Aug 10, 2020 |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| 4 | Insider transaction | Aug 14, 2020 | Aug 12, 2020 |
| CORRESP | Letter to the SEC | Aug 14, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Aug 12, 2020 | — |
| S-3 | Shelf registration | Aug 7, 2020 | — |
| 8-K |
Current report
Other events
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Other events
|
Jul 24, 2020 | Jul 22, 2020 |
| 10-K/A | Amended annual report | Jul 13, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Jun 29, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Other events
|
Jun 19, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2020 | Jun 16, 2020 |
| 424B5 | Prospectus supplement | Jun 18, 2020 | — |
| 8-K |
Current report
Other events
|
Jun 16, 2020 | Jun 16, 2020 |
| 424B5 | Prospectus supplement | Jun 16, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 16, 2020 | Jun 16, 2020 |
| 10-K/A | Amended annual report | Jun 16, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
May 15, 2020 | May 15, 2020 |
| 10-K | Annual report | May 8, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 5, 2020 | May 5, 2020 |
| 8-K |
Current report
Listing notice
|
May 5, 2020 | Apr 29, 2020 |
| SC 13G | Ownership over 5% (passive) | May 1, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 27, 2020 | — |
| 8-K |
Current report
Material agreement
|
Apr 24, 2020 | Apr 21, 2020 |
| 424B5 | Prospectus supplement | Apr 22, 2020 | — |
| 424B5 | Prospectus supplement | Apr 21, 2020 | — |
| 8-K |
Current report
Other events
|
Mar 27, 2020 | Mar 20, 2020 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 8, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 19, 2019 | Dec 18, 2019 |
| 8-K |
Current report
Other events
|
Dec 3, 2019 | Dec 2, 2019 |
| DEF 14A | Proxy statement | Nov 25, 2019 | Dec 18, 2019 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 25, 2019 | Nov 25, 2019 |
| PRE 14A | Preliminary proxy statement | Nov 15, 2019 | Nov 15, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| SC 13G | Ownership over 5% (passive) | Oct 31, 2019 | — |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 4 | Insider transaction | Jul 16, 2019 | Jul 12, 2019 |
| 8-K |
Current report
Other events
|
Jun 7, 2019 | Jun 7, 2019 |
| 10-Q | Quarterly report | May 10, 2019 | Mar 31, 2019 |
| S-8 | Employee stock plan registration | May 10, 2019 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 18, 2019 | Apr 18, 2019 |
| 424B5 | Prospectus supplement | Apr 18, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Apr 18, 2019 | — |
| 424B5 | Prospectus supplement | Apr 17, 2019 | — |
| 10-K | Annual report | Mar 15, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Mar 12, 2019 | Mar 6, 2019 |
| 4 | Insider transaction | Mar 7, 2019 | Mar 5, 2019 |
| 4 | Insider transaction | Feb 21, 2019 | Feb 21, 2019 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2019 | — |
| 424B5 | Prospectus supplement | Dec 28, 2018 | — |
| 8-K |
Current report
Material agreement
|
Dec 28, 2018 | Dec 28, 2018 |
| 8-K |
Current report
Officer or director change
|
Dec 26, 2018 | Dec 21, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Dec 21, 2018 | Dec 18, 2018 |
| 4 | Insider transaction | Dec 10, 2018 | Dec 10, 2018 |
| 4 | Insider transaction | Dec 10, 2018 | Dec 10, 2018 |
| 4 | Insider transaction | Nov 20, 2018 | Nov 19, 2018 |
| DEF 14A | Proxy statement | Nov 16, 2018 | Dec 18, 2018 |
| 10-Q | Quarterly report | Nov 9, 2018 | Sep 30, 2018 |
| PRE 14A | Preliminary proxy statement | Oct 30, 2018 | Nov 8, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATNM (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1388320
- Former names
- Cactus Ventures, Inc. (until Mar 29, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.